Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

225937-10-0

(+)-Catechin Hydrate

225937-10-0
53-21-4

Cocaine HCl

53-21-4
21593-23-7

Cephapirin

21593-23-7
50-23-7

Hydrocortisone

50-23-7
53-06-5

Cortisone

53-06-5
NA

Carbidopa Impurity G

NA
1093072-86-6

Citalopram desfluoro oxalate (rac)

1093072-86-6
461-05-2

Carnitine DL HCl

461-05-2
23325-78-2

Cephalexine H2O

23325-78-2
41354-29-4

Cyproheptadine HCl 1/2 H2O

41354-29-4
77-91-8

Choline citrate dihydrogen

77-91-8
80-97-7

Beta-Cholestanol

80-97-7
139481-59-7

Candesartan

139481-59-7
154361-50-9

Capecitabine

154361-50-9
82009-34-5

Cilastatin

82009-34-5
21898-19-1

Clenbuterol HCl

21898-19-1
38083-17-9

Climbazole

38083-17-9
58207-19-5

Clindamycin HCl Monohydrate

58207-19-5
1015247-88-7

Clopidogrel Carboxylic Acid HCl

1015247-88-7
6059-47-8

Codeine Monohydrate

6059-47-8